Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CleanSpark Inc (CLSK) vs Revvity Inc (RVTY) Price & Performance

CleanSpark IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

CleanSpark Inc vs Revvity Inc — how do they compare? CleanSpark Inc trades at $13.67 (market cap $3.45B), while Revvity Inc trades at $111.62 (market cap $12.41B). The key difference: Revvity Inc is far larger — about 3.6× CleanSpark Inc's market cap, and Revvity Inc pays a 0.25% dividend while CleanSpark Inc pays none. Which is the better fit depends on your goals.

CLSKRVTY
Market Cap
$3.45B$12.41B
Sector
TechnologyTechnology
52-Week High
$23.20$117.75
52-Week Low
$8.18$82.26
Enterprise Value
$4.31B$14.90B
Dividend Yield
0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CleanSpark Inc

CleanSpark (CLSK) trades at $12.36, down 3.81% today, with a bearish technical signal and recent earnings misses. The company reported a net loss margin of -67.66% for 2026 but announced a transformative $6.6 billion 20-year AI data center lease, shifting focus from Bitcoin mining to high-performance computing. Analyst consensus remains unanimously bullish with a $21.43 price target, highlighting growth potential despite current profitability challenges.

The outlook balances high growth potential from the AI pivot against significant execution risks and persistent losses. Near-term volatility is expected as the market assesses the company's ability to monetize new contracts and achieve sustainable profitability. The stock presents a high-risk, high-reward opportunity dependent on successful business model transition.

Revvity Inc

RVTY trades at $111.11, down 1.05% today, with a bullish technical signal from moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.06 exceeding expectations. Recent developments include AI integration with Anthropic's Claude and FDA clearance for a testosterone assay, signaling innovation in diagnostics and life sciences.

The outlook remains positive with strong analyst support (51.72% buy ratings) and a consensus price target of $111.43. Key risks include margin pressure from China divestment plans and weak academic demand. Revenue stability around $2.9B supports valuation, though high P/E of 53.47 requires sustained growth to justify.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CleanSpark Inc

CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.

Read more on CLSK

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY